Bioprinting certainly will play a major role in the future of medicine. Implantation of 3D printed bones, soft tissue, and eventually entire organs look to be on the horizon. With several companies working on the technology, and the science behind 3D bioprinting making huge strides in recent years, the entire medical field may be in for major disruptions.
Swansea University-based life science technology company 3Dynamic Systems Ltd (3DS) has developed two new additive manufacturing systems, but with a difference. These machines are capable of depositing a range of biologically active and biologically compatible materials. The company is working to fabricate 3D transplantable bone and complex tissue constructs on demand. This exciting breakthrough in tissue engineering technology developed by the company could one day be used to treat severely injured patients. The research has successfully engineered a suitable bone composite and a 3D-Bioprinting technology to make high complexity tissue structures. These have been determined to be optimum materials for producing reliable extra cellular matrix-based tissues.
The first system is the 3Dynamic Alpha Series, which is a single extrusion bone tissue fabrication platform. This machine produces calcium phosphate-based bone for regenerating severe non-stabalised fractures. By accurately depositing a special bone composite in 3D, the correct anatomical geometry is produced. This material is seeded with platelet-derived growth factor which creates the right environment for tissue regeneration by recruiting stem cells that can produce bone and forming a supportive structure, including blood vessels.
The second system is the dual extrusion 3Dynamic Omega Series bioprinter which is used to make three dimensional soft tissue constructs. Currently this is capable of producing heterogeneous tissues which are used for pharmaceutical testing trials. This technique is also being explored as a method for bioprinting different tissues including; muscle, adipose and skin. With this technology, techniques are being developed which could be an effective means toward producing transplantable complex tissues on demand.
3DS’ easy to use technology could see a greater adoption of bioprinting research and further innovation in the short-term by enabling researches in the field to effectively produce experimental tissues and multiple tissue types on demand. As a result the bioprinting technology developed by 3DS could one day transform the field of reconstructive medicine which may lead to direct bio-engineering replacement human tissues on-demand for transplantation. For further information visit bioprintingsystems.com. Let’s hear your thoughts on 3D bioprinting, and these new techniques in the 3Dynamic Systems bioprinting forum thread on 3DPB.com.
You May Also Like
3D Printing News Briefs, November 24, 2021: 3D Printing Steel, Glass, Skin Models, & More
In today’s 3D Printing News Briefs, we’re starting with a roundtable discussion on AM workforce development. Then we’re moving on to research, first about 3D printing a better steel, and...
ABCorp Adds Desktop Metal 3D Printing to its Boston Center of Excellence
American Banknote Corporation (ABCorp), one of the oldest manufacturing services providers in the United States, is announcing another expansion to its Center of Excellence in Boston. Back in May, ABCorp...
Nexa3D Reveals New 3D Printers, Executives, & Oqton Partnership at Formnext
As Formnext 2021 winds down in Frankfurt, Germany, we’re learning more about some of the announcements made during the event. We recently told you that Nexa3D, which specializes in developing...
Formnext 2021: First Day Impressions of Post-Lockdown 3D Printing
Formnext is back and we’ve headed once more to Frankfurt, the lovely city where you can see people smoking crack on the street at 19:00 while the financiers zoom by...
View our broad assortment of in house and third party products.